Evidence map›Paper›PMID 42036388›Full record

ArticlePhysiological reports2026

LQT1 patients have augmented response of repolarization dispersion following atropine induced heart rate increase versus healthy controls.

Pia Dahlberg, Karl-Jonas Axelsson, Steen M Jensen, Gunilla Lundahl, Lennart Gransberg, Lennart Bergfeldt

Abstract read
In one paragraph

Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pia DahlbergDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Karl-Jonas AxelssonDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Steen M JensenHeart Centre, Umeå University Hospital, Umeå, Sweden.
Gunilla LundahlDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Lennart GransbergDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Lennart BergfeldtDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-0161-9388

Funding

Hjärt-Lungfonden (Swedish Heart-Lung Foundation) 20230703Swedish Government and County Councils ALF-agreement ALFGBG-1006070
6 · The paper itself

Abstract

The long QT syndrome type 1 (LQT1) is caused by loss-of-function mutations affecting the potassium channel current I

Indexed as

AtropineHeart RateRomano-Ward SyndromeAdultElectrocardiographyFemaleHumansMaleMiddle AgedVectorcardiographyYoung AdultAtropineatropineheart rate increaselong QT syndromerepolarization dispersionvectorcardiographyventricular repolarization

Identifiers

PMID42036388
PMCPMC13111145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.